
MindWalk Holdings Corp.
MindWalk Holdings Corp. (HYFT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HYFT · as of Jun 9, 2026
Key Statistics
Explore MindWalk Holdings Corp. Data
hyft stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The HYFT analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +212.50% upside from the current price of $1.60.
Competitors & Peers
hyft competitorsStock Performance
Full HistoryAbout MindWalk Holdings Corp.
MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated la…
what is mindwalk holdings corp. · hyft stock overview · mindwalk holdings corp. company profile · who is mindwalk holdings corp. ceo · hyft NASDAQ · mindwalk holdings corp. headquarters · mindwalk holdings corp. business segments
About Stock Overview & Key Data
MindWalk Holdings Corp. (HYFT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 7, 2002. As of the latest trading session, HYFT stock price is $1.60, with a market capitalization of $74.7M. The stock has returned +138.88% over the past 12 months and -12.09% year-to-date.
According to 2 Wall Street analysts, the consensus rating for MindWalk Holdings Corp. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, MindWalk Holdings Corp. reported revenue of $24.5M and net income of -$30.2M. For detailed data — including MindWalk Holdings Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MindWalk Holdings Corp. (HYFT) stock price is $1.60. The stock is traded on NASDAQ under the ticker symbol HYFT. The 52-week range is $0.51 – $3.25.